Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00986 |
| Species: | Homo sapiens |
| Position : | chr6:142706180-142706230 |
| Year: | 2019 |
| Title: | Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 30755618 |
| MONDO: | |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | N2A cells |
| CVCL ID: | CVCL_0470 |
| Cell Type: | neuroblastoma cell |
| Cell Ontology ID: | CL:0000031 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | RT-RT-qPCR, Western blot |
| Target gene : | ADGRG6 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|